Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report

Management of ticagrelor-associated bleeding is challenging, especially in neurosurgery. Platelet transfusion is inefficient and no antidote is currently available. We report here the first case of recombinant activated factor VII (rFVIIa) use to bypass ticagrelor-induced platelet inhibition. A woma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:TH Open
Main Authors: Godier, Anne, Dupont, Mélanie, Desilles, Jean-Philippe, Le Guerinel, Caroline, Taylor, Guillaume, Perrin, Mathilde, Martin, Anne-Céline, Gaussem, Pascale
Formato: Artigo
Idioma:Inglês
Publicado em: Georg Thieme Verlag KG 2018
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524896/
https://ncbi.nlm.nih.gov/pubmed/31249959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0038-1672211
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados